BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Short (1M)
Nirmal Bang Recommends 'Buy' On Natco Pharma
According to Nirmal Bang, Natco Pharma's growth strategy remains focused around limited-competition products, but it is now looking at markets beyond the US. A successful entry in China can be highly meaningful as new product launches can potentially be as lucrative as the US market, the brokerage adds.